CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Genus PLC - GNSgb CFD

    18.91
    4.2%
    0.18
    Low: 18.87
    High: 19.69
    Market Trading Hours* (UTC) Opens on Monday at 08:00

    Mon - Fri: 08:00 - 16:30

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.18
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.025262 %
    Charges from full value of position ($-4.80)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.025262%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003344 %
    Charges from full value of position ($0.64)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.003344%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency GBP
    Margin 5%
    Stock exchange United Kingdom of Great Britain and Northern Ireland
    Commission on trade 0%

    *Information provided by Capital.com

    Genus PLC ESG Risk Ratings

    High Medium Low Negligible

    ‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 19.74
    Open* 19.56
    1-Year Change* -32.64%
    Day's Range* 18.87 - 19.69
    52 wk Range 19.76-32.30
    Average Volume (10 days) 209.36K
    Average Volume (3 months) 2.86M
    Market Cap 1.36B
    P/E Ratio 40.50
    Shares Outstanding 66.03M
    Revenue 689.70M
    EPS 0.51
    Dividend (Yield %) 1.5534
    Beta 0.30
    Next Earnings Date Feb 22, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Dec 1, 2023 18.91 -0.74 -3.77% 19.65 19.77 18.80
    Nov 30, 2023 19.74 0.09 0.46% 19.65 19.89 19.53
    Nov 29, 2023 19.88 -0.03 -0.15% 19.91 20.35 19.73
    Nov 28, 2023 20.07 -0.22 -1.08% 20.29 20.29 19.77
    Nov 27, 2023 20.41 -0.22 -1.07% 20.63 20.97 20.35
    Nov 24, 2023 20.67 0.00 0.00% 20.67 20.99 20.57
    Nov 23, 2023 20.87 0.68 3.37% 20.19 21.07 20.19
    Nov 22, 2023 20.33 -0.12 -0.59% 20.45 20.87 20.07
    Nov 21, 2023 21.15 -0.80 -3.64% 21.95 22.27 21.05
    Nov 20, 2023 22.19 0.38 1.74% 21.81 22.61 21.81
    Nov 17, 2023 22.09 0.18 0.82% 21.91 22.33 21.75
    Nov 16, 2023 21.71 -0.76 -3.38% 22.47 22.85 21.71
    Nov 15, 2023 22.47 0.54 2.46% 21.93 22.81 21.77
    Nov 14, 2023 21.93 1.80 8.94% 20.13 22.17 20.13
    Nov 13, 2023 20.23 -0.30 -1.46% 20.53 20.91 20.23
    Nov 10, 2023 20.71 -0.58 -2.72% 21.29 21.55 20.71
    Nov 9, 2023 21.45 0.38 1.80% 21.07 21.65 20.97
    Nov 8, 2023 21.59 0.12 0.56% 21.47 21.73 20.85
    Nov 7, 2023 21.47 -0.06 -0.28% 21.53 21.91 21.15
    Nov 6, 2023 21.87 -0.62 -2.76% 22.49 22.85 21.75

    Genus PLC Events

    Time (UTC) Country Event
    Wednesday, February 21, 2024

    Time (UTC)

    08:30

    Country

    GB

    Event

    Half Year 2024 Genus PLC Earnings Release
    Half Year 2024 Genus PLC Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2023 2022 2021 2020 2019
    Total revenue 689.7 593.4 574.3 551.4 488.5
    Revenue 689.7 593.4 574.3 551.4 488.5
    Cost of Revenue, Total 309.3
    Gross Profit 179.2
    Total Operating Expense 649.2 544 526.6 509 479.8
    Selling/General/Admin. Expenses, Total 6 3.7 7.7 5.8 71
    Research & Development 54.9
    Depreciation / Amortization 7.7 8.3 6.9
    Unusual Expense (Income) 20.4 7.4 14.1 3.4 37.7
    Operating Income 40.5 49.4 47.7 42.4 8.7
    Interest Income (Expense), Net Non-Operating -3 -0.5 9 4.9 1.6
    Other, Net 1.9 -0.5 -0.9 -1 -0.4
    Net Income Before Taxes 39.4 48.4 55.8 46.3 9.9
    Net Income After Taxes 31.8 36.7 46.8 35.7 6.7
    Minority Interest 1.5 4.2 0.5 -0.4 1.1
    Net Income Before Extra. Items 33.3 40.9 47.3 35.3 7.8
    Net Income 33.3 40.9 47.3 35.3 7.8
    Income Available to Common Excl. Extra. Items 33.3 40.9 47.3 35.3 7.8
    Income Available to Common Incl. Extra. Items 33.3 40.9 47.3 35.3 7.8
    Dilution Adjustment
    Diluted Net Income 33.3 40.9 47.3 35.3 7.8
    Diluted Weighted Average Shares 65.557 65.395 65.662 65.427 65.304
    Diluted EPS Excluding Extraordinary Items 0.50795 0.62543 0.72036 0.53953 0.11944
    Dividends per Share - Common Stock Primary Issue 0.32 0.32 0.32 0.291 0.277
    Diluted Normalized EPS 0.75911 0.71123 0.90046 0.63735 0.5091
    Total Extraordinary Items
    Other Operating Expenses, Total 615.1 524.6 504.8 499.8
    Jun 2023 Dec 2022 Jun 2022 Dec 2021 Jun 2021
    Total revenue 339.5 350.2 312.2 281.2 288.6
    Revenue 339.5 350.2 312.2 281.2 288.6
    Total Operating Expense 313.7 335.5 286.7 257.3 276.4
    Selling/General/Admin. Expenses, Total 3.7 2.3 1.5 2.2 3.4
    Depreciation / Amortization 2.9 4.8 4.5 3.8
    Unusual Expense (Income) 1 19.4 2.3 5.1 9
    Other Operating Expenses, Total 306.1 309 278.4 246.2 264
    Operating Income 25.8 14.7 25.5 23.9 12.2
    Interest Income (Expense), Net Non-Operating -3.6 0.6 -1.8 1.3 4.8
    Other, Net 2.2 -0.3 0.3 -0.8 0.1
    Net Income Before Taxes 24.4 15 24 24.4 17.1
    Net Income After Taxes 19.8 12 17.8 18.9 16.5
    Minority Interest 0.1 1.4 3.2 1 -0.7
    Net Income Before Extra. Items 19.9 13.4 21 19.9 15.8
    Net Income 19.9 13.4 21 19.9 15.8
    Income Available to Common Excl. Extra. Items 19.9 13.4 21 19.9 15.8
    Income Available to Common Incl. Extra. Items 19.9 13.4 21 19.9 15.8
    Dilution Adjustment
    Diluted Net Income 19.9 13.4 21 19.9 15.8
    Diluted Weighted Average Shares 65.133 65.981 65.395 65.82 65.714
    Diluted EPS Excluding Extraordinary Items 0.30553 0.20309 0.32113 0.30234 0.24044
    Dividends per Share - Common Stock Primary Issue 0.217 0.103 0.217 0.103 0.217
    Diluted Normalized EPS 0.31799 0.43831 0.34721 0.36236 0.37259
    • Annual
    • Quarterly
    2023 2022 2021 2020 2019
    Total Current Assets 259 257.5 231.7 223.8 209.2
    Cash and Short Term Investments 36.3 38.8 46 41.3 30.5
    Cash 36.3 38.8 46 41.3 30.5
    Total Receivables, Net 128.4 125 102.2 103.9 101.3
    Accounts Receivable - Trade, Net 113.9 108.7 89.9 100.8 98
    Total Inventory 85.1 84 76.6 37.4 36
    Prepaid Expenses 7.7 8.5 6.6
    Other Current Assets, Total 1.5 1.2 0.3 41.2 41.4
    Total Assets 1007.5 1017.9 851 855.4 795.5
    Property/Plant/Equipment, Total - Net 482.6 505.1 402.9 428 373.1
    Property/Plant/Equipment, Total - Gross 629.3 637 503.3
    Accumulated Depreciation, Total -146.7 -131.9 -100.4
    Goodwill, Net 107.8 111 101.5 105.6 106.3
    Intangibles, Net 66.2 72 56.3 62.9 72
    Long Term Investments 62.3 51.4 48.8 29.6 31
    Other Long Term Assets, Total 21.4 12.3 8 3.7 3.9
    Total Current Liabilities 147.2 151.3 142.5 130.2 104.2
    Accounts Payable 34.8 36 23.7
    Accrued Expenses 7.7 9 8.2
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 14.2 17.2 22.9 19.2 4.3
    Other Current Liabilities, Total 90.5 89.1 87.7 16 12.2
    Total Liabilities 432.6 439.4 352.9 360.9 315.2
    Total Long Term Debt 217.9 206.6 128.7 124.7 105.8
    Long Term Debt 196 182.1 109.4 103.6 101.9
    Capital Lease Obligations 21.9 24.5 19.3 21.1 3.9
    Deferred Income Tax 51.2 60.3 53 65.5 66.7
    Minority Interest -7.7 -6.4 -1.5 0 -1.3
    Other Liabilities, Total 24 27.6 30.2 40.5 39.8
    Total Equity 574.9 578.5 498.1 494.5 480.3
    Common Stock 6.6 6.6 6.6 6.5 6.5
    Additional Paid-In Capital 179.1 179.1 179.1 179.1 179
    Retained Earnings (Accumulated Deficit) 360.6 340.6 320.4 280.7 258.9
    Treasury Stock - Common -0.1 -0.1 -0.1 -0.1 -0.1
    Other Equity, Total 28.7 52.3 -7.9 28.3 36
    Total Liabilities & Shareholders’ Equity 1007.5 1017.9 851 855.4 795.5
    Total Common Shares Outstanding 66.0272 65.7736 65.7615 65.0916 65.0546
    Note Receivable - Long Term 8.2 8.6 1.8 1.8 0
    Payable/Accrued 95 87.7
    Jun 2023 Dec 2022 Jun 2022 Dec 2021 Jun 2021
    Total Current Assets 259 271.4 257.5 249.3 231.7
    Cash and Short Term Investments 36.3 42.3 38.8 45.9 46
    Cash 36.3 42.3 38.8 45.9 46
    Total Receivables, Net 128.4 126.5 133.5 121.7 108.8
    Accounts Receivable - Trade, Net 113.9 111.9 129.5 118.1 106.2
    Total Inventory 85.1 90.1 50.9 44.3 37
    Other Current Assets, Total 1.5 1.1 34.3 37.4 39.9
    Total Assets 1007.5 1024.1 1017.9 896.2 851
    Property/Plant/Equipment, Total - Net 482.6 491 505.1 430.4 402.9
    Property/Plant/Equipment, Total - Gross 629.3 632 637 537 503.3
    Goodwill, Net 107.8 111.7 111 102.2 101.5
    Intangibles, Net 66.2 68.4 72 55.4 56.3
    Long Term Investments 62.3 60.8 51.4 52 48.8
    Note Receivable - Long Term 8.2 8.1 8.6 1.8 1.8
    Other Long Term Assets, Total 21.4 12.7 12.3 5.1 8
    Total Current Liabilities 147.2 133.6 151.3 140.7 142.5
    Payable/Accrued 124.7 113.1 110.3
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 14.2 17.2 17.2 19.2 22.9
    Other Current Liabilities, Total 90.5 76.5 9.4 8.4 9.3
    Total Liabilities 432.6 446 439.4 387.1 352.9
    Total Long Term Debt 217.9 239.6 206.6 170 128.7
    Long Term Debt 196 214.9 182.1 151 109.4
    Capital Lease Obligations 21.9 24.7 24.5 19 19.3
    Deferred Income Tax 51.2 55.8 60.3 50.9 53
    Minority Interest -7.7 -8.2 -6.4 -2.7 -1.5
    Other Liabilities, Total 24 25.2 27.6 28.2 30.2
    Total Equity 574.9 578.1 578.5 509.1 498.1
    Common Stock 6.6 6.6 6.6 6.6 6.6
    Additional Paid-In Capital 179.1 179.1 179.1 179.1 179.1
    Retained Earnings (Accumulated Deficit) 360.6 344 340.6 327.7 320.4
    Treasury Stock - Common -0.1 -0.1 -0.1 -0.1 -0.1
    Other Equity, Total 28.7 48.5 52.3 -4.2 -7.9
    Total Liabilities & Shareholders’ Equity 1007.5 1024.1 1017.9 896.2 851
    Total Common Shares Outstanding 66.0272 65.7736 65.7736 65.7701 65.7615
    Accumulated Depreciation, Total -146.7 -141 -131.9 -106.6 -100.4
    Prepaid Expenses 7.7 11.4
    Accounts Payable 34.8 31.5
    Accrued Expenses 7.7 8.4
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line 36.7 46.8 35.7 6.7 41.6
    Cash From Operating Activities 34.3 67.5 60.1 33.4 43.2
    Cash From Operating Activities 26.4 24 24 12.6 10.4
    Amortization 12.6 11.1 13.1 13.7 13.8
    Non-Cash Items 3.3 -0.9 1.1 20.5 -7.5
    Cash Taxes Paid 17.5 16.1 13.5 12.5 11.6
    Cash Interest Paid 5.1 3.6 4.4 3.3 3.9
    Changes in Working Capital -44.7 -13.5 -13.8 -20.1 -15.1
    Cash From Investing Activities -67.2 -46.7 -25 -46.1 -20.8
    Capital Expenditures -65.4 -33.8 -29.7 -28.3 -22.5
    Other Investing Cash Flow Items, Total -1.8 -12.9 4.7 -17.8 1.7
    Cash From Financing Activities 21.9 -14.2 -23.1 13.6 -19.1
    Financing Cash Flow Items -0.7 -2.1 0 0
    Total Cash Dividends Paid -20.9 -19.5 -18.3 -16.8 -14.9
    Issuance (Retirement) of Stock, Net 0 0.1 0.1 66.5 0.1
    Issuance (Retirement) of Debt, Net 43.5 7.3 -4.9 -36.1 -4.3
    Foreign Exchange Effects 3.8 -1.9 -1.2 0.5 -0.7
    Net Change in Cash -7.2 4.7 10.8 1.4 2.6
    Dec 2022 Jun 2022 Dec 2021 Jun 2021 Dec 2020
    Net income/Starting Line 12 36.7 18.9 46.8 30.3
    Cash From Operating Activities 11.8 34.3 11.6 67.5 38.1
    Cash From Operating Activities 14.9 26.4 12.2 24 11.9
    Amortization 7.7 12.6 5.8 11.1 6.1
    Non-Cash Items 14.5 3.3 6.1 -0.9 -2.1
    Cash Taxes Paid 8.7 17.5 8.3 16.1 5.3
    Cash Interest Paid 5 5.1 2.1 3.6 1.8
    Changes in Working Capital -37.3 -44.7 -31.4 -13.5 -8.1
    Cash From Investing Activities -18.2 -67.2 -29.5 -46.7 -18.3
    Capital Expenditures -15 -65.4 -27.8 -33.8 -11.9
    Other Investing Cash Flow Items, Total -3.2 -1.8 -1.7 -12.9 -6.4
    Cash From Financing Activities 11.6 21.9 17.4 -14.2 -9.6
    Total Cash Dividends Paid -14.2 -20.9 -14.2 -19.5 -12.8
    Issuance (Retirement) of Stock, Net 0 0 0.1 0
    Issuance (Retirement) of Debt, Net 27 43.5 32.2 7.3 5.3
    Foreign Exchange Effects -1.7 3.8 0.4 -1.9 -1.3
    Net Change in Cash 3.5 -7.2 -0.1 4.7 8.9
    Financing Cash Flow Items -1.2 -0.7 -0.6 -2.1 -2.1
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Baillie Gifford & Co. Investment Advisor 8.8297 5830181 -85451 2022-10-01 LOW
    BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund 5.4868 3622898 -217618 2022-10-01 LOW
    Wellington Management Company, LLP Investment Advisor/Hedge Fund 5.2795 3485992 237010 2023-06-06 LOW
    Columbia Threadneedle Investments (UK) Investment Advisor/Hedge Fund 5.0819 3355521 -484995 2022-10-01 LOW
    Aberdeen Standard Investments (Edinburgh) Investment Advisor 4.9846 3291292 3098275 2023-05-23 LOW
    Capital Research Global Investors Investment Advisor 4.976 3285610 -752637 2023-08-23 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 4.4997 2971117 26381 2022-10-01 LOW
    Devon Equity Management Ltd. Investment Advisor 4.0498 2674080 0 2022-10-01 LOW
    Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 2.4466 1615497 0 2023-10-01 LOW
    Legal & General Investment Management Ltd. Investment Advisor/Hedge Fund 1.8797 1241140 -8615 2023-10-01 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 1.8058 1192344 0 2023-10-01 LOW
    Credit Suisse Funds AG Investment Advisor/Hedge Fund 1.7837 1177743 -31708 2023-06-22 LOW
    The National Farmers Union Mutual Insurance Society Limited Insurance Company 1.6372 1081055 14770 2023-06-22 LOW
    T. Rowe Price International Ltd Investment Advisor/Hedge Fund 1.5623 1031592 -30883 2023-06-20 LOW
    Columbia Wanger Asset Management, LLC Investment Advisor 1.2319 813410 0 2023-08-31 MED
    Fidelity International Investment Advisor 1.1891 785145 -25954 2023-06-20 LOW
    M&G Investment Management Ltd. Investment Advisor 1.018 672187 0 2023-10-01 LOW
    Newton Investment Management Ltd. Investment Advisor 1.0012 661075 37829 2023-06-22 LOW
    Columbia Threadneedle Management Limited Investment Advisor/Hedge Fund 0.9971 658396 0 2023-10-01 LOW
    Royal London Asset Management Ltd. Investment Advisor/Hedge Fund 0.9322 615522 25676 2023-10-01 MED

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Genus Company profile

    Genus PLC (GNS) is a is a world-leading animal genetics business. Headquartered in Basingstoke, UK, it sells products produced using biotechnology to pig and cattle farmers. The business has manufacturing facilities in key locations around the world, paired with sales forces in 75 countries. The Genus share price is listed on the London Stock Exchange and included in the FTSE 250 Index. The company’s beginnings date back to 1933 when the Milk Marketing Board’s Breeding and Production Division was founded in the UK. The key breakthrough in the Genus development happened in 1999 when the business acquired ABS Global, a US-based company founded by J.R. Prentice. As of 2018, the company’s annual revenue was £470.3 million. Check the GNS share price at Capital.com.
    Industry: Biotechnology & Medical Research (NEC)

    Matrix House
    Basing View
    BASINGSTOKE
    HAMPSHIRE RG21 4DZ
    GB

    Income Statement

    • Annual
    • Quarterly

    News

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023
    GBP

    UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?

    UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.

    10:48, 21 November 2023

    People also watch

    BTC/USD

    40,656.80 Price
    +2.260% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    XRP/USD

    0.64 Price
    +0.730% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 22:00 (UTC)
    Spread 0.01168

    US100

    15,947.80 Price
    -0.300% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 1.8

    Oil - Crude

    73.76 Price
    -0.990% 1D Chg, %
    Long position overnight fee -0.0136%
    Short position overnight fee -0.0083%
    Overnight fee time 22:00 (UTC)
    Spread 0.030

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading